Platelet function in cutaneous diseases

Platelets

Volumn 19, Issue 5, 2008, Pages 317-321

  Kasperska Zajac, Alicja ^a   Brzoza, Zenon ^a   Rogala, Barbara ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Atopic eczema dermatitis syndrome; Platelet activation; Psoriasis; Urticaria

Indexed keywords

ATOPIC DERMATITIS; DERMATITIS; HUMAN; HYPERSENSITIVITY; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; REVIEW; SKIN DISEASE; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; URTICARIA;

ANIMALS; BLOOD COAGULATION DISORDERS; BLOOD PLATELETS; BLOOD PROTEINS; CHEMOKINES; DERMATITIS; HUMANS; MICE; PLATELET ACTIVATION; PSORIASIS; SKIN DISEASES; URTICARIA;

EID: 51849100315     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100802082249     Document Type: Review

References (42)

1. Kantarci A, Van-Dyke TE. Lipoxins in- chronic inflammation. Crit Rev Oral Biol Med 2003;14:4-12.
2. Herd CM, Page CP. Pulmonary immune cells in health and disease: Platelets. Eur Respir J 1994;7:1145-1160.
3. Elzey BD, Tian J, Jensen RJ, Swanson AK, Lees JR, Lentz SR, Stein CS, Nieswandt B, Wang Y, Davidson BL, Ratliff TL. Platelet-mediated modulation of adaptative immunity: A communication link between innate and adaptive immune compartments. Immunity 2003;19:9-19.
4. Ludwig RJ, Schultz JE, Boehncke WH, Podda M, Tandi C, Krombach F, Baatz H, Kaufmann R, von Andrian UH, Zollner TM. Activated, not resting, platelets increase leukocyte rolling in murine skin utilizing a distinct set of adhesion molecules. J Invest Dermatol 2004;122:830-836.
5. Kaplan KL, Owen J. Plasma levels of β-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 1981;57:199-202.
6. Deuel TF, Senior RM, Chang D, Griffin GL, Heinrikson RL, Kaiser ET. Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci USA 1981;78:4584-4587.
7. Bruijnzeel PL, Kuijper PH, Rihs S, Betz S, Warringa RA, Koenderman L. Eosinophil migration in atopic dermatitis. I: Increased migratory responses to N-formyl-methionylleucyl-phenylalanine, neutrophil-activating factor, platelet-activating factor, and platelet factor 4. J Invest Dermatol 1993;100:137-142.
8. Fricke I, Mitchell D, Petersen F, Bohle A, Bulfone-Paus S, Brandau S. Platelet factor 4 in conjunction with IL-4 directs differentiation of human monocytes into specialized antigen-presenting cells. FASEB J 2004;18:1588-1590.
9. Gregg EO, Yarwood L, Wagstaffe MJ, Pepper DS, Macdonald MC. Immunomodulatory properties of platelet factor 4: Prevention of concanavalin A suppressor-induction in vitro and augmentation of an antigen-specific delayed-type hypersensitivity response in vivo. Immunology 1990;70:230-234.
10. Kameyoshi Y, Dörschner A, Mallet AI, Christophers E, Schröder JM. Cytokine RANTES released by thrombin-stimulated platelets is a potent atrractent for human eosinophils. J Exp Med 1992;176:587-592.
11. Geba GP, Ptak W, Anderson GM, Paliwal V, Ratzlaff RE, Levin J, Askenase PW. Delayed-type hypersensitivity in mast cell-deficient mice: Dependence on platelets for expression of contact sensitivity. J Immunol 1996;157:557-565.
12. Greaves MW, Camp RD. Prostaglandins, leukotrienes, phospholipase, platelet activating factor, and cytokines: An integrated approach to inflammation of human skin. Arch Dermatol Res 1988;280 Suppl:S33-S41.
13. Mitsuhashi M, Tanaka A, Fujisawa C, Kawamoto K, Itakura A, Takaku M, Hironaka T, Sawada S, Matsuda H. Necessity of thromboxane A2 for initiation of platelet-mediated contact sensitivity: Dual activation of platelets and vascular endothelial cells. J Immunol 2001;166:617-623.
14. Kasperska-Zajac A, Rogala B. Platelet activation during allergic inflammation. Inflammation 2007;30:161-166.
15. Hasegawa S, Pawankar R, Suzuki K, Nakahata T, Furukawa S, Okumura K, Ra C. Functional expression of the high affinity receptor for IgE (FcepsilonRI) in human platelets and its intracellular expression in human megakaryocytes. Blood 1999;93:2543-2551.
16. Joseph M, Capron A, Ameisen JC, Capron M, Vorng H, Pancré V, Kusnierz JP, Auriault C. The receptor for IgE on blood platelets. Eur J Immunol 1986;16:306-312.
17. Kowal K, Pampuch A, Kowal-Bielecka O, DuBuske LM, Bodzenta- Łukaszyk A. Platelet activation in allergic asthma patients during allergen challenge with Dermatophagoides pteronyssinus. Clin Exp Allergy 2005;36:426-432.
18. Hilger R, Neuber AK, König W. Conversion of leukotriene A4 by neutrophils and platelets from patients with atopic dermatitis. Immunology 1991;74:689-695.
19. Neuber K, Hilger RA, König W. Differential increase in 12-HETE release and CD29/CD49f expression of platelets from normal donors and from patients with atopic dermatitis. Int Arch Allergy Immunol 1992;98:339-342.
20. Watanabe O, Natori K, Tamari M, Shiomoto Y, Kubo S, Nakamura Y. Significantly elevated expression of PF4 (platelet factor 4) and eotaxin in the NOA mouse, a model for atopic dermatitis. J Hum Genet 1999;44:173-176.
21. Kasperska-Zajac A, Nowakowski M, Rogala B. Enhanced platelet activation in patients with atopic eczema/dermatitis syndrome. Inflammation 2004;28:299-302.
22. Fujisawa T, Fujisawa R, Kato Y, Nakayama T, Morita A, Katsumata H, Nishimori H, Iguchi K, Kamiya H, Gray PW et al. Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis. J Allergy Clin Immunol 2002;110:139-146.
23. Yamada H, Chihara J, Matsukura M, Yasuba H, Yudate T, Tezuka T. Elevated plasma RANTES levels in patients with atopic dermatitis. J Clin Lab Immunol 1996;48:87-91.
24. Gluck J, Rogala B. Chemokine RANTES in atopic dermatitis. Arch Immunol Ther Exp (Warsz) 1999;47:367-372.
25. Rogala B, Gumprecht J, Glück J. Platelet aggregation in atopic dermatitis. Platelets 1999;10:341-344.
26. Kasperska-Zajac A, Rogala B. Markers of platelet activation in plasma of patients suffering from persistent allergic rhinitis with or without asthma symptoms. Clin Exp Allergy 2005;35:1462-1465.
27. Greaves M.W. Chronic urticaria. N Engl J Med 1995;332:1767-1772.
28. Wasserman SI, Ginsberg MH. Release of platelet factor 4 into the blood after cold challenge of patients with cold urticaria. J Allergy Clin Immunol 1984;74:275-279.
29. Eady RAJ, Keahey TM, Sibbald RG, Kobza-Black A. Cold urticaria with vasculitis: Report of a case with light and electron microscopic, immunofluorescence and pharmacological studies. Clin Exp Dermatol 1981;6:355-356.
30. Rosenkranz AR, Wekkeli M, Hippmann G, Benda H, Jarisch R, Götz M. Cold urticaria as a model of mediator release: Platelet factor 4, eosinophil cationic protein and histamine. Allergy 1992;47:366-370.
31. Kasperska-Zajac A, Rogala B, Nowakowski M. Assessment of platelet activity, expressed by plasma levels of platelet factor 4 and beta-thromboglobulin in patients with chronic idiopathic urticaria. Exp Dermatol 2005;14:515-518.
32. Kasperska-Zajac A, Brzoza Z, Rogala B. Circulating level of the platelet-derived CXC chemokine platelet factor 4 in chronic urticaria patients with or without coexistent euthyroid Hashimoto's thyroiditis. Autoimmunity 2006;39:265-268.
33. Kasperska-Zajac A, Brzoza Z, Rogala B. Plasma concentration of platelet factor 4 in patients with acute urticaria in the course of acute respiratory tract infection. Adv Clin Exp Med 2006;15:995-998.
34. Vila L, Sola J, Puig L, de-Castellarnau C, de-Moragas JM. Exogenous arachidonic acid metabolism in platelets from psoriatic patients. Acta Derm Venereol 1990;70:110-114.
35. Vila L, Cullare C, Sola J, Puig L, de Castellarnau C, de Moragas JM. Cyclooxygenase activity is increased in platelets from psoriatic patients. J Invest Dermatol 1991;97:922-926.
36. Hayashi S, Shimizu I, Miyauchi H, Watanabe S. Increased platelet aggregation in psoriasis. Acta Derm Venereol 1985;65:258-262.
37. Kragballe K, Fallon JD. Increased aggregation and arachidonic acid transformation by psoriatic platelets: Evidence that platelet-derived 12-hydroxy-eicosatetraenoic acid increases keratinocyte DNA synthesis in vitro. Arch Dermatol Res 1986;278:449-453.
38. Berrettini M, Parise P, Costantini V, Grasselli S, Nenci GG. Platelet activation in psoriasis. Thromb Haemost 1985;53:195-197.
39. Wolf R, Machtey I, Feuerman EJ, Creter D. Blood hyperviscosity in psoriasis. Acta Derm-Venereol 1981;61:153-154.
40. Ena P, Madeddu P, Glorioso N, Cerimele D, Rappelli A. High prevalence of cardiovascular diseases and enhanced activity of the renin-angiotensin system in psoriatic patients. Acta-Cardiol 1985;40:199-205.
41. McDonald CJ, Calabresi P. Psoriasis and occlusive vascular disease. Br J Dermatol 1978;99:469-475.
42. Rocha Pereira P, Santos Silva A, Rebelo I, Figueiredo A, Quintanilha A, Teixeira F. Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease. Clin Chim Acta 2001;303:33-39.